Turka Laurence A.
Chief Scientific Officer at Rubius Therapeutics, Inc.
- Sold, on record
- $17k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Jan 31, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Rubius Therapeutics, Inc.Chief Scientific Officer
Sales by reason
0
Routine
1
Plan not stated
0
No plan
1
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Jan 31, 2023Plan not stated
Sold 12.4% of their holdings
$6222,593 shares at $0.24
- Feb 1, 2022Unusual
Sold 33.8% of their holdings
$17k2,517 shares at $6.57
2 of 2
Every transaction
Loading transactions…
Sales and notices (2)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 | Jan 31, 2023 | Rubius Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 2,593 | $622 | 12.4% | Plan not stated | SEC |
| Feb 1, 2022 | Feb 1, 2022 | Rubius Therapeutics, Inc. | Chief Scientific Officer | Form 4 sale | 2,517 | $17k | 33.8% | Unusual | SEC |